Alkylating agent-related acute myeloid leukemia

Clinical trials for Alkylating agent-related acute myeloid leukemia explained in plain language.

Never miss a new study

Get alerted when new Alkylating agent-related acute myeloid leukemia trials appear

Sign up with your email to follow new studies for Alkylating agent-related acute myeloid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 2

Can a 'Priming' drug boost chemo for tough leukemia?

Disease control Ongoing

This phase 2 trial tests whether adding the drug decitabine to standard chemotherapy improves remission rates in adults with acute myeloid leukemia (AML) who have less favorable genetic risk. Decitabine is given before chemo to try to make cancer cells more sensitive. About 178 p…

Matched conditions: ALKYLATING AGENT-RELATED ACUTE MYELOID LEUKEMIA

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 12:25 UTC

Alkylating agent-related acute myeloid leukemia

Get alerted when new Alkylating agent-related acute myeloid leukemia trials appear

Can a 'Priming' drug boost chemo for tough leukemia?